AMH levels and IVF stimulation

Rumpík, David; Rumpíková, Taťána; Kučera, Radek; Loucký, Jaroslav; Bělašková, Silvie; Topolčan, Ondřej

dc.title	AMH levels and IVF stimulation	en
dc.contributor.author	Rumpík, David
dc.contributor.author	Rumpíková, Taťána
dc.contributor.author	Kučera, Radek
dc.contributor.author	Loucký, Jaroslav
dc.contributor.author	Bělašková, Silvie
dc.contributor.author	Topolčan, Ondřej
dc.relation.ispartof	17th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI)
dc.identifier.isbn	978-88-6521-063-5
dc.date.issued	2013
dc.citation.spage	57
dc.citation.epage	59
dc.event.title	17th World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI)
dc.event.location	Lisbon
utb.event.state-en	Portugal
utb.event.state-cs	Portugalsko
dc.event.sdate	2012-11-08
dc.event.edate	2012-11-11
dc.type	conferenceObject
dc.language.iso	en
dc.publisher	Monduzzi Editore S P A
dc.description.abstract	The goal of this study was to evaluate the utility of anti-Mullerian hormone (AMH) serum levels for prediction of gonadotropin dose for stimulation prior to an IVF cycle. In conclusion, AMH is a good predictor for the dose of gonadotropins. A lower value of AMH corresponds with the high consumption of gonadotropins during the stimulation process. A low level of AMH predicts a high dose of gonadotropins, required during stimulation and also predicts a poorer yield of oocytes.	en
utb.faculty	Faculty of Applied Informatics
dc.identifier.uri	http://hdl.handle.net/10563/1004588
utb.identifier.obdid	43869623
utb.identifier.wok	000316867100009
utb.source	d-wok
dc.date.accessioned	2015-05-28T11:39:27Z
dc.date.available	2015-05-28T11:39:27Z
utb.contributor.internalauthor	Bělašková, Silvie